Betamethasone Dipropionate recalls
The FDA has published 8 recalls involving Betamethasone Dipropionate since 2019. The latest was reported on 15 Jun 2022. Most were for potency & assay. Teligent Pharma has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls8since 2019
Last 12 months0reported
Class I00% of total
Ongoing1latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 50%Class III 4 50%
Why betamethasone dipropionate is recalled
Companies
By year
Ongoing betamethasone dipropionate recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented) recalled | McKesson | Potency & Assay | Nationwide |
All betamethasone dipropionate recalls, newest first
8 totalShould you stop taking Betamethasone Dipropionate?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.